Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating real-time patient-reported outcomes in colorectal cancer care: development and evaluation of a concise clinical scorecard.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitationยท2026
Same author

Robotic Right Hemicolectomy with Complete Mesocolic Excision and D3 Lymphadenectomy: Perioperative Complications and Oncologic Outcomes.

Surgical oncology insightยท2026
Same author

Risk of Metachronous Colorectal Cancer After Segmental or Extended Resection in Patients with Lynch Syndrome.

Journal of the American College of Surgeonsยท2026
Same author

ASO Visual Abstract: Incidence and Predictors of Neoplastic Diagnosis in Patients with a Clinically Abnormal Appendix.

Annals of surgical oncologyยท2026
Same author

Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma.

Nature communicationsยท2026
Same author

Risk of Residual Cancer following Immediate Surgery or Nonoperative Management after Malignant Colorectal Polypectomy with High-Risk Features.

JCO oncology advancesยท2026
Same journal

Modern Assessment of Resident and Board-Certified Colorectal Surgeon: Evolution of Competency and Continuing Professional Development.

Clinics in colon and rectal surgeryยท2026
Same journal

Faculty Development: Cultivating Educators, Advancing Careers, and Lifelong Learning.

Clinics in colon and rectal surgeryยท2026
Same journal

Constructive Conversations: Mastering the Exchange of Feedback.

Clinics in colon and rectal surgeryยท2026
Same journal

Surgical Education for the Colorectal Surgeon: Theories, Principles, and Practice.

Clinics in colon and rectal surgeryยท2026
Same journal

Cultivating Inclusion: The Role of DE&I in Colorectal Surgery Training.

Clinics in colon and rectal surgeryยท2026
Same journal

International Perspective on Colorectal Surgery Education.

Clinics in colon and rectal surgeryยท2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Anorectal melanoma.

David Row1, Martin R Weiser

  • 1Colorectal Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Clinics in Colon and Rectal Surgery
|May 4, 2010
PubMed
Summary
This summary is machine-generated.

Anorectal melanoma is a rare, lethal cancer distinct from cutaneous melanoma. Research explores its features, outcomes, and potential targeted therapies, offering new hope for this difficult-to-diagnose disease.

Keywords:
Melanomaadjuvant treatmentanorectal diseasemolecular therapy

More Related Videos

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Related Experiment Videos

Last Updated: Jun 13, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Area of Science:

  • Gastroenterology
  • Oncology
  • Pathology

Background:

  • Anorectal melanoma is an uncommon and lethal malignancy.
  • It presents diagnostic challenges and has a poor prognosis.
  • Distinguishing it from cutaneous melanoma is crucial.

Purpose of the Study:

  • To review the epidemiologic, clinicopathologic, and molecular features of anorectal melanoma.
  • To compare anorectal melanoma with its cutaneous counterpart.
  • To discuss surgical outcomes, survival predictors, and adjuvant therapies.

Main Methods:

  • Literature review and synthesis of existing data.
  • Analysis of epidemiologic, clinicopathologic, and molecular characteristics.
  • Evaluation of surgical resection outcomes and therapeutic strategies.

Main Results:

  • Anorectal melanoma exhibits unique features compared to cutaneous melanoma.
  • Surgical management remains controversial with variable outcomes.
  • KIT oncogene activation identified in a subset of patients.

Conclusions:

  • Anorectal melanoma requires distinct diagnostic and management approaches.
  • Targeted molecular therapies, potentially including KIT inhibitors, show promise.
  • Further research is needed to improve survival rates for this rare cancer.